JAK2 and myeloproliferative disorder: By leveraging high-throughput screening techniques and advanced computational tools, we sought to discover compounds that exhibit high affinity and selectivity for the mutant JAK2 kinase, crucial for driving MPN and validating them for biological efficacy.